@article{aeb9f3475360478aa667b84eb2c87376,
title = "Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247–1251",
author = "Gaetano Santulli and Salvatore Frullone and Maria Morgante and Gaetano Macina and Antonella Pansini and Jessica Gambardella and Angela Lombardi and Pasquale Mone",
note = "Funding Information: Funding. The laboratory of G.S. is supported in part by the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK123259 and R01-DK033823) and National Heart, Lung, and Blood Institute (R01-HL146691, R01-HL164772, R01-HL159062, and T32-HL144456) and by the Irma T. Hirschl and Monique Weill-Caulier Trusts (to G.S.), the Diabetes Action Research and Education Foundation (to G.S.), and the American Heart Association (AHA-20POST35211151 to J.G.).",
year = "2022",
month = oct,
doi = "10.2337/dci22-0025",
language = "English (US)",
volume = "45",
pages = "e151--e152",
journal = "Diabetes care",
issn = "0149-5992",
publisher = "American Diabetes Association Inc.",
number = "10",
}
